AlphaYou
Overview
No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.
Key stats
Aug 20- 52-wk high
- $25.77
- 52-wk low
- $4.52
- Prev close
- $14.84
- Mkt cap
- $1.35B
- Fwd P/E
- 10.9x
- Beta
- 1.53
Smart money
Earnings
Earnings came in 72.0% below what analysts expected.
Financials
What it sold, what it cost, what was left.
Sep 2025Dec 2025Mar 2026Jun 2026
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $12.8M | $2.8M | $4.2M | $9.0M |
| Cost of what it sold | $2.1M | $2.1M | $2.0M | — |
| Gross profit | $12.8M | $2.8M | $2.2M | $9.0M |
| What it spent | ||||
| Research and development | $36.7M | $42.0M | $44.1M | $48.0M |
| Sales and admin | $9.1M | $10.5M | $10.2M | $10.1M |
| Other operating costs | — | — | -$2.0M | — |
| Total operating expenses | $45.7M | $52.5M | $52.2M | $58.1M |
| What was left | ||||
| Operating profit | -$33.0M | -$49.7M | -$50.0M | -$49.1M |
| Profit before tax | -$30.3M | -$46.1M | -$44.5M | -$43.2M |
| Tax | -$3.2M | $59.0K | $52.0K | $208.0K |
| Net profit | -$27.1M | -$46.1M | -$44.5M | -$43.4M |
| EBITDA | -$28.2M | -$44.0M | -$42.4M | -$41.3M |
Technicals
Price structure
No data yet
Technicals sync when verified market data is available. No sample data is shown.
News
What the news says
23 articles · 7 days
Coverage leans bearish
Tone of tracked coverage
Alphabet Inc. Buys Shares of 372,474 Monte Rosa Therapeutics, Inc. $GLUE
NeutralAug 18Widening Losses And Profitability Swing Might Change The Case For Investing In Monte Rosa Therapeutics (GLUE)
BearishAug 16Widening Losses And Profitability Swing Might Change The Case For Investing In Monte Rosa Therapeutics (GLUE)
Bearish
